Vismodegib — Drug Intelligence | 4 EU Trials

Filter these 4 trials by condition, phase, country and more.

4 Registered trials

3 Recruiting

0 Completed trials

4 Sponsors

4 Countries

Phase II

Phase II: 4

Oversight events:

1 serious breach 2 urgent safety measures across 2 trials

Sponsors using this IMP

4 total

Molecularly Tailored Therapy versus Standard Care in Advanced Pancreatic Cancer Pending

2025-522431-34-00 Phase II 1 country Region Hovedstaden
FINPROVE - The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs Recruiting

2024-517478-68-01 Phase II 1 country HUS-Yhtymae
Improving public cancer care by implementing precision medicine in Norway Recruiting

2023-507894-16-00 Phase II 1 country Oslo University Hospital HF
DRUP trial Recruiting

2023-509152-33-00 Phase II 1 country Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Showing 1–4 of 4 trials